Company intelligence / Profile preview

NextPharma

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

NextPharma provides end-to-end pharmaceutical development and manufacturing services from early-stage development through clinical trial supply to commercial manufacturing. The company operates nine FDA-approved sites in Europe with expertise in solids, semi-solids, nonsterile/sterile liquids, hormones, antibiotics (penicillins/cephalosporins), narcotics, pediatric medicines and more. It serves over 70 global markets with strong regulatory compliance.

Modalities: Small moleculeBiologic (including hormones)Peptides (including modified release and lipid-based formulations)Antibiotics (penicillins/cephalosporins)NarcoticsSemi-solid and liquid dosage formsPediatric medicinal productsNutraceuticals
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on NextPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NextPharma.

Explore the full profile